Physician profile
Sanjay Digamber
NPI 1497142236
$1,544.62
in general payments reported to CMS, 2019-2025
9 companies · $448 in 2025
The $448 reported for 2025 was more than what 77% of Physical Medicine & Rehabilitation providers received nationally (typical 2025 total: $138).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $159 · 2020: $68.95 · 2022: $142 · 2023: $236 · 2024: $491 · 2025: $448.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,058 · Travel and Lodging: $116.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,058.07 |
| Travel and Lodging | $115.89 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $409.35 | 2019-2025 | Infinity, Proclaim, Octrode |
| Nevro Corp. | $393.82 | 2023-2024 | Senza |
| Medtronic, INC. | $321.85 | 2022-2024 | Intellis Adaptivestim |
| Boston Scientific Corporation | $221.82 | 2020-2025 | Wavewriter Alpha Prime 16, General - Pain Management |
| Si-Bone, INC. | $62.89 | 2022-2024 | |
| Vertiflex, INC. | $44.76 | 2019 | |
| Globus Medical, INC. | $39.31 | 2022 | |
| Siemens Medical Solutions USA, INC. | $36.96 | 2024 | Cios Select |
| Kowa Pharmaceuticals America, INC. | $13.86 | 2023 | Seglentis |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sanjay Digamber listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.